Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalData Regulatory News (DATA)

Share Price Information for GlobalData (DATA)

Share Price is delayed by 15 minutes
Get Live Data
85.20    -5.90 (-6.48%)
Bid:
85.50
Ask:
86.00
Spread: 0.50 (0.585%)
Market Cap: £591.69m
DATA Live PriceLast checked at - London Stock Exchange

Intraday GlobalData Share Chart

Transaction in Own Shares

23 Aug 2024 07:00

RNS Number : 4977B
GlobalData PLC
23 August 2024
Β 

23 August 2024

Β 

Β 

GlobalData Plc

Β 

Transaction in Own Shares

Β 

Β 

GlobalData Plc ('GlobalData' or the 'Group') announces that, in accordance with the terms of its share buyback programme announced and commenced on 31 July 2024 (the "Share Buyback Programme"), the Company purchased the following number of its ordinary shares of Β£0.0001 each through Panmure Liberum Limited.

Β 

Β 

Date of purchase:

22 August 2024

Aggregate number of ordinary shares of Β£0.0001 each purchased:

275,000

Lowest price paid per share (GBp):

222.0

Highest price paid per share (GBp):

222.0

Volume weighted average price paid per share (GBp):

222.0

Β 

The Group will cancel the repurchased shares. Following the purchase of these shares, the remaining number of ordinary shares in issue will be 841,518,898 and the Group holds no ordinary shares in treasury. Therefore, the total voting rights in GlobalData will be 841,518,898. This figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Β 

In accordance with Article 5(1)(b) of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Panmure Liberum Limited as part of the Share Buyback Programme.

Β 

Aggregate Information:

Β 

Venue

Volume-weighted average price (pence per share)

Aggregated volume

XLON

222.0

275,000

Β 

Individual transactions:

Β 

Number of shares purchased

Transaction price (pence per share)

Time of transaction

Venue

275,000

222.0

10:46:16

AIMX

Β 

Β 

ENQUIRIES

Β 

GlobalData Plc

Mike Danson, Chief Executive Officer

0207 936 6400

Graham Lilley, Chief Financial Officer

J.P. Morgan Cazenove (Nomad, Joint Broker)

0203 493 8000

Bill Hutchings

Mose Adigun

Panmure Liberum (Joint Broker)

0207 886 2500

Rupert Dearden

Dougie McLeod

Investec Bank plc (Joint Broker)

Henry Reast

Virginia BullΒ 

0207 597 5970

Β 

FTI Consulting (Financial PR)

0203 727 1000

Edward Bridges

globaldata@fticonsulting.com

Dwight Burden

Emma Hall

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
POSEAKPAASFLEFA
Date   Source Headline
4th Feb 20267:00 amRNSUpdate on Move to the Main Market
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20269:00 amRNSNotification of Major Holdings
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSBoard changes
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20267:00 amRNSTrading Update and Update on move to Main Market
14th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
24th Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20257:00 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSTransaction in Own Shares
16th Dec 20257:00 amRNSTransaction in Own Shares
15th Dec 20257:00 amRNSTransaction in Own Shares
12th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20257:00 amRNSTransaction in Own Shares
10th Dec 20257:00 amRNSTransaction in Own Shares
9th Dec 20257:00 amRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20253:24 pmRNSHolding(s) in Company
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.